HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Y Lai Selected Research

nilotinib

2/2020[Analysis of the efficacy and influencing factors of nilotinib or dasatinib as second- or third-line treatment in patients with chronic myeloid leukemia in the chronic phase and accelerated phase].
12/2019[Comparison of nilotinib vs imatinib as frontline therapy in newly diagnosed patients with chronic myeloid leukemia in chronic phase].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Y Lai Research Topics

Disease

11BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2023 - 12/2016
3Poisoning
11/2020 - 02/2019
2Cytopenia
04/2023 - 07/2019
2Thrombocytopenia (Thrombopenia)
04/2023 - 04/2019
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2022 - 06/2016
2Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
07/2021 - 07/2019
2Neoplasms (Cancer)
07/2019 - 07/2019
1Graves Disease (Basedow Disease)
04/2024
1Neutropenia
07/2022
1Infections
07/2022
1Acne Vulgaris
04/2022
1Edema (Dropsy)
04/2022
1Erythema
04/2022
1Pain (Aches)
04/2022
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
06/2021
1Pleural Effusion (Pleural Effusions)
12/2020
1Pulmonary Arterial Hypertension
12/2020
1Coma (Comas)
11/2020
1Splenomegaly
12/2019
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2019
1Philadelphia Chromosome
07/2019
1Chromosome Aberrations (Chromosome Abnormalities)
07/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2019
1monosomy Chromosome 7
07/2019
1Ataxia (Dyssynergia)
05/2019
1Leukopenia
04/2019
1Polyps
03/2019
1Nasal Polyps (Nasal Polyp)
03/2019
1Rhinosinusitis
03/2019
1Optic Nerve Diseases (Optic Neuropathy)
09/2017
1Leukemia
06/2016
1Sleep Wake Disorders
08/2013
1REM Sleep Behavior Disorder
08/2013
1Cognitive Dysfunction
08/2013
1Neurologic Manifestations (Neurological Manifestations)
08/2013
1Parkinson Disease (Parkinson's Disease)
09/2007
1Muscle Hypotonia (Hypotonia)
05/2001

Drug/Important Bio-Agent (IBA)

6Tyrosine Kinase InhibitorsIBA
04/2023 - 11/2017
3Imatinib Mesylate (Gleevec)FDA Link
12/2019 - 12/2016
2Dasatinib (BMS 354825)FDA Link
12/2020 - 02/2020
2nilotinibFDA Link
02/2020 - 12/2019
2trimethyltin chlorideIBA
05/2019 - 02/2019
1IodineIBA
04/2024
1Hemoglobins (Hemoglobin)IBA
04/2023
1Immunoglobulin A (IgA)IBA
04/2022
1Lactic Acid (Lactate)FDA LinkGeneric
11/2020
1Carbon DioxideIBA
11/2020
1Phosphotransferases (Kinase)IBA
06/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2019
1Indicators and Reagents (Reagents)IBA
07/2019
1OxidesIBA
05/2019
1trimethyltinIBA
05/2019
1Prednisone (Sone)FDA LinkGeneric
03/2019
1Oxidoreductases (Dehydrogenase)IBA
03/2019
1GlucocorticoidsIBA
03/2019
1Neuroprotective AgentsIBA
09/2007
1Interleukin-1 (Interleukin 1)IBA
09/2007
1Interleukin-1alpha (Interleukin 1 alpha)IBA
09/2007
1OrexinsIBA
05/2001

Therapy/Procedure

7Therapeutics
04/2024 - 08/2013
2Drug Therapy (Chemotherapy)
07/2022 - 07/2021
2Induction Chemotherapy
06/2021 - 06/2016
1Erythrocyte Transfusion
07/2022
1Lasers (Laser)
04/2022
1Aftercare (After-Treatment)
04/2022
1Consolidation Chemotherapy
10/2019
1Activities of Daily Living (ADL)
05/2019
1Decompression
09/2017
1Salvage Therapy
09/2017
1Maintenance Chemotherapy
06/2016